Cargando…

Atrial pacing–induced oversensing in subcutaneous implantable cardioverter-defibrillator

Detalles Bibliográficos
Autores principales:	Wharmby, Amy, Butcher, Charles, Elliott, James, Monkhouse, Christopher, Goswell, Ciaran, Lambiase, Pier D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10265186/ https://www.ncbi.nlm.nih.gov/pubmed/37324961 http://dx.doi.org/10.1016/j.hrcr.2023.01.016

Ejemplares similares

Oversensing of atrial fibrillatory waves in a subcutaneous implantable cardioverter-defibrillator
por: Karnik, Ankur A., et al.
Publicado: (2017)

Mobile subcutaneous implantable cardioverter-defibrillator leads to oversensing and inappropriate shocks
por: Kiamanesh, Omid, et al.
Publicado: (2019)

T-Wave Oversensing with Contemporary Implantable Cardioverter–Defibrillators
por: Strik, Marc, et al.
Publicado: (2023)

Right ventricular function is a predictor for sustained ventricular tachycardia requiring anti-tachycardic pacing in arrhythmogenic ventricular cardiomyopathy: insight into transvenous vs. subcutaneous implantable cardioverter defibrillator insertion
por: Honarbakhsh, Shohreh, et al.
Publicado: (2023)

Letter to the Editor: Inappropriate subcutaneous implantable cardioverter‐defibrillator discharge related to myopotential oversensing
por: Chery, Godefroy, et al.
Publicado: (2020)

Exploiting SMART pass filter deactivation detection to minimize inappropriate subcutaneous implantable cardioverter defibrillator therapies: a real-world single-centre experience and management guide
por: Monkhouse, Christopher, et al.
Publicado: (2023)

Oversensing caused by trapped air in the header of subcutaneous cardioverter‐defibrillator generator
por: Okada, Takuya, et al.
Publicado: (2023)

Subcutaneous implantable defibrillator in dextrocardia secondary to Lobectomy
por: Monkhouse, Christopher, et al.
Publicado: (2018)

DF-4 defibrillator downgrade to pacemaker, a novel method of device downgrade for implantable cardioverter-defibrillator patients
por: Monkhouse, Christopher, et al.
Publicado: (2023)

Oversensing of an unexpected atrial flutter. A new tool to improve detection of supraventricular arrhythmias in subcutaneous implantable cardioverter-defibrillators
por: Santini, Luca, et al.
Publicado: (2017)

S-ICD oversensing detected by remote monitoring using a new atrial fibrillation diagnostic algorithm
por: Monkhouse, Christopher, et al.
Publicado: (2018)

Inappropriate shocks by subcutaneous implantable cardioverter-defibrillator due to T-wave oversensing in hyperkalemia leading to ventricular fibrillation
por: Kiamanesh, Omid, et al.
Publicado: (2015)

Inappropriate Subcutaneous Implantable Cardioverter Defibrillator Shocks Secondary to Cardiac Remodeling: A Unique Case of T Wave Oversensing
por: Saleem, Maleeha, et al.
Publicado: (2022)

Time course of oversensing and impedance changes in developing implantable cardioverter-defibrillator lead fracture
por: Himes, Adam, et al.
Publicado: (2022)

Routine exercise testing could not predict T‐wave oversensing in a patient after a subcutaneous implantable cardioverter‐defibrillator implant
por: Konishi, Shozo, et al.
Publicado: (2017)

T-wave oversensing during drug challenge test after subcutaneous implantable cardioverter-defibrillator implantation in a patient with Brugada syndrome
por: Kamakura, Tsukasa, et al.
Publicado: (2016)

Oversensing of the wearable cardioverter defibrillator during bipolar ventricular stimulation
por: Manninger, Martin, et al.
Publicado: (2017)

Inappropriate shock from delayed T-wave oversensing by a subcutaneous implantable cardioverter-defibrillator after septal myectomy for hypertrophic cardiomyopathy
por: Salgado, Benjamin C., et al.
Publicado: (2018)

T wave oversensing in subcutaneous implantable cardioverter defibrillator secondary to hematoma formation: A potential cause of early postimplantation inappropriate shocks
por: Halawa, Ahmad, et al.
Publicado: (2018)

Induced atrial fibrillation during defibrillation test on implantation of subcutaneous implantable cardioverter defibrillator
por: Kim, Ki-Hun, et al.
Publicado: (2020)

Subcutaneous implantable cardioverter-defibrillators: long-term results of the EFFORTLESS study
por: Lambiase, Pier D, et al.
Publicado: (2022)

A case of inappropriate implantable cardioverter defibrillator therapy induced by T-wave oversensing due to hyperkalemia
por: Aoki, Kosuke, et al.
Publicado: (2015)

Changing place, changing future: Repositioning a subcutaneous implantable cardioverter-defibrillator can resolve inappropriate shocks secondary to myopotential oversensing
por: Berne, Paola, et al.
Publicado: (2017)

Inappropriate shocks from a subcutaneous implantable cardioverter-defibrillator due to oversensing during periods of rate-related bundle branch block
por: Sousa, Maria João, et al.
Publicado: (2017)

Process mapping strategies to prevent subcutaneous implantable cardioverter‐defibrillator infections
por: Weiss, Raul, et al.
Publicado: (2022)

The Subcutaneous Implantable Cardioverter-Defibrillator: Not For All
por: Nair, Krishnakumar, et al.
Publicado: (2014)

The subcutaneous implantable cardioverter-defibrillator should be considered for all patients with an implantable cardioverter-defibrillator indication
por: Tan, Jian Liang, et al.
Publicado: (2022)

Two cases of inappropriate implantable cardioverter-defibrillator therapies due to T wave oversensing induced by body twisting
por: Nishii, Nobuhiro, et al.
Publicado: (2017)

Diagnosis and management of subcutaneous implantable cardioverter‐defibrillator infections based on process mapping
por: Baddour, Larry M., et al.
Publicado: (2020)

T-wave oversensing during left ventricular pacing causing inappropriate defibrillation
por: Payne, Joshua, et al.
Publicado: (2017)

Predictors of Elevated Defibrillation Threshold with the Subcutaneous Implantable Cardioverter-defibrillator
por: Do, Khuyen, et al.
Publicado: (2017)

Need for pacing in patients who qualify for an implantable cardioverter‐defibrillator: Clinical implications for the subcutaneous ICD
por: Kutyifa, Valentina, et al.
Publicado: (2020)

Subcutaneous Implantable Cardioverter Defibrillator: Early Experience
por: Souza, Fernando Sérgio Oliva, et al.
Publicado: (2017)

Subcutaneous implantable cardioverter-defibrillator placement in a patient with a preexisting transvenous implantable cardioverter-defibrillator
por: Jazayeri, Mohammad-Ali, et al.
Publicado: (2017)

Pause-prevention pacing in an extravascular implantable cardioverter-defibrillator
por: Sagi, Venkata, et al.
Publicado: (2023)

Inappropriate Shock Delivered By Implantable Cardioverter Defibrillator - Cardiac Resynchronization Therapy (ICD-CRT) Due To Myopotential Oversensing
por: Barakpour, Hamid, et al.
Publicado: (2009)

The subcutaneous implantable cardioverter defibrillator––review of the recent data
por: Westerman, Stacy B, et al.
Publicado: (2018)

Subcutaneous Implantable Cardioverter-Defibrillator Shock: Appropriate or Inappropriate?
por: Ip, James E.
Publicado: (2017)

An “UninTENSional” Subcutaneous Implantable Cardioverter-defibrillator Shock
por: Turner, Suzette L., et al.
Publicado: (2018)

Inappropriate subcutaneous implantable cardioverter-defibrillator shocks for bradycardia
por: Chua, Kelvin C.M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_a8mb8jkft4ao5ouch1oh7f7rg6